首页> 外文OA文献 >A phase I study of PankoMab-GEX, a humanised glyco-optimised monoclonal antibody to a novel tumour-specific MUC1 glycopeptide epitope in patients with advanced carcinomas

【2h】

A phase I study of PankoMab-GEX, a humanised glyco-optimised monoclonal antibody to a novel tumour-specific MUC1 glycopeptide epitope in patients with advanced carcinomas

机译：PankoMab-GEX的I期研究，这是一种针对新型肿瘤特异性MUC1糖肽表位的人源化糖优化单克隆抗体，用于晚期癌症

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Fiedler W.; DeDosso S.; Cresta S.; Weidmann J.; Tessari A.; Salzberg M.; Dietrich B.; Baumeister H.; Goletz S.; Gianni L.; Sessa C.;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. A phase I study of PankoMab-GEX, a humanised glyco-optimised monoclonal antibody to a novel tumour-specific MUC1 glycopeptide epitope in patients with advanced carcinomas [J] . Fiedler W., DeDosso S., Cresta S., European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2016,第Null期

机译：PankoMab-GEX的I期研究，这是一种针对新型肿瘤特异性MUC1糖肽表位的人源化糖优化单克隆抗体，用于晚期癌症
2. A phase I open-label dose-escalation study of the anti-HER3 monoclonal antibody LJM716 in patients with advanced squamous cell carcinoma of the esophagus or head and neck and HER2-overexpressing breast or gastric cancer [J] . Kerry Lynn Reynolds, Philippe L. Bedard, Se-Hoon Lee, BMC Cancer . 2017,第1期

机译：抗HER3单克隆抗体LJM716在晚期食道或头颈部鳞状细胞癌和HER2过表达的乳腺癌或胃癌患者中的I期开放标签剂量递增研究
3. A phase I open-label dose-escalation study of the anti-HER3 monoclonal antibody LJM716 in patients with advanced squamous cell carcinoma of the esophagus or head and neck and HER2-overexpressing breast or gastric cancer [J] . Kerry Lynn Reynolds, Philippe L. Bedard, Se-Hoon Lee, BMC Cancer . 2017,第1期

机译：抗HER3单克隆抗体LJM716在晚期食道或头颈部鳞状细胞癌和HER2过表达的乳腺癌或胃癌患者中的I期开放标签剂量递增研究
4. An anti-MUC1 monoclonal antibody for radioimmunoscintigraphy of breastcancer: indirect labeling of antibody via the HYNIC with 99mTc; in vitro and invivo studies of new radiopharmaceutical [C] . M.Salouti, H.Rajabi, H.Babaei, Trends in Radiopharmaceuticals(ISTR-2005) . 2007

机译：用于乳腺癌放射免疫显像的抗MUC1单克隆抗体：通过HYNIC间接标记99mTc的抗体;新放射性药物的体外和体内研究
5. Humanization of a MUC16-Specific Monoclonal Antibody and Characterization of the MUC16 Epitope [D] . White, Brandy R. 2019

机译：MUC16特异性单克隆抗体的人源化和MUC16表位的表征
6. A phase I open-label dose-escalation study of the anti-HER3 monoclonal antibody LJM716 in patients with advanced squamous cell carcinoma of the esophagus or head and neck and HER2-overexpressing breast or gastric cancer [O] . Kerry Lynn Reynolds, Philippe L. Bedard, Se-Hoon Lee, 2017

机译：抗HER3单克隆抗体LJM716在晚期食道或头颈部鳞状细胞癌以及HER2过表达的乳腺癌或胃癌患者中进行的I期开放标签剂量递增研究
7. Phase I study of GC1008 (fresolimumab): a human anti-transforming growth factor-beta (TGFβ) monoclonal antibody in patients with advanced malignant melanoma or renal cell carcinoma. [O] . John C Morris, Antoinette R Tan, Thomas E Olencki, 2014

机译：GC1008（fresolimumab）的I期研究：人类抗转化生长因子-β（TGFβ）单克隆抗体用于晚期恶性黑素瘤或肾细胞癌患者。
8. Monoclonal Antibodies and Cancer. Studies on the Use of Monoclonal Antibodies for Imaging and Therapy of Cancer, with Special Emphasis on Ovarian Carcinoma [R] . Haisma, H. J. 1987

机译：单克隆抗体和癌症。单克隆抗体在癌症成像和治疗中的应用研究，特别强调卵巢癌

A phase I study of PankoMab-GEX, a humanised glyco-optimised monoclonal antibody to a novel tumour-specific MUC1 glycopeptide epitope in patients with advanced carcinomas

著录项

相似文献

相关主题

期刊订阅